These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 337916

  • 1. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
    Muss HB, White DR, Cooper MR, Richards F, Spurr CL.
    Arch Intern Med; 1977 Dec; 137(12):1711-4. PubMed ID: 337916
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S.
    Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT, Palshof T.
    Prog Clin Biol Res; 1977 Jan 01; 12():459-66. PubMed ID: 335404
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA, Grillo-López A, Vélez-Garciá E.
    Bol Asoc Med P R; 1975 Jun 01; 67(6):157-63. PubMed ID: 1055588
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
    Mouridsen HT, Palshof T, Brahm M, Rahbek I.
    Cancer Treat Rep; 1977 Jun 01; 61(1):47-50. PubMed ID: 324620
    [Abstract] [Full Text] [Related]

  • 7. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT, Palshof T, Brahm M, Rahbek I.
    Ugeskr Laeger; 1977 Oct 31; 139(44):2632-5. PubMed ID: 929742
    [No Abstract] [Full Text] [Related]

  • 8. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL, Joergensen ST, Roesdahl K, Thomsen J, Mouridsen HT.
    Cancer Treat Rep; 1978 Mar 31; 62(3):449-50. PubMed ID: 348314
    [No Abstract] [Full Text] [Related]

  • 9. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
    Cocconi G, Di Blasio B, Boni C, Bisagni G, Ceci G, Rondini E, Bella M, Leonardi F, Savoldi L, Camisa R, Bruzzi P.
    Cancer; 2002 Jul 15; 95(2):228-35. PubMed ID: 12124820
    [Abstract] [Full Text] [Related]

  • 10. [Chemotherapy of metastasizing breast cancers. Indications and results].
    Gallmeier WM, Bruntsch U, Schmidt CG.
    Dtsch Med Wochenschr; 1975 Jan 10; 100(2):35-41. PubMed ID: 1112210
    [Abstract] [Full Text] [Related]

  • 11. [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
    Nüvemann M, Fernholz HJ, Frik W.
    Med Klin; 1976 Oct 01; 71(40):1676-83. PubMed ID: 184372
    [Abstract] [Full Text] [Related]

  • 12. [Association of VCR-5FU-CYCLO-PDN in the treatment of disseminated carcinoma of the breast (author's transl)].
    Estapé J, Millá A, Prats M, Herranz M, Visa J.
    Med Clin (Barc); 1979 Aug 15; 73(4):136-9. PubMed ID: 481010
    [Abstract] [Full Text] [Related]

  • 13. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM, Abeloff MD, Lenhard RE, Baker RR.
    Surg Gynecol Obstet; 1974 Jan 15; 138(1):77-80. PubMed ID: 4809006
    [No Abstract] [Full Text] [Related]

  • 14. A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes.
    Ludwig Breast Cancer Study Group.
    Cancer Res; 1985 Sep 15; 45(9):4454-9. PubMed ID: 2862995
    [Abstract] [Full Text] [Related]

  • 15. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW, Martz G, Senn HJ, Obrecht P, Alberto P, Melchert F.
    Internist (Berl); 1973 Dec 15; 14(12):643-52. PubMed ID: 4593011
    [No Abstract] [Full Text] [Related]

  • 16. Chemotherapy of breast cancer.
    Mitchell MS.
    Conn Med; 1975 Jan 15; 39(1):4-5. PubMed ID: 1109851
    [No Abstract] [Full Text] [Related]

  • 17. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA, Marcrae KD.
    Ann R Coll Surg Engl; 1974 Jun 15; 54(6):275-6. PubMed ID: 4833779
    [No Abstract] [Full Text] [Related]

  • 18. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV, Bartolucci AA.
    Eur J Cancer (1965); 1980 Jun 15; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract] [Full Text] [Related]

  • 19. Chemotherapy for breast cancer.
    Allegra JC, Lippman ME.
    Compr Ther; 1979 Feb 15; 5(2):13-7. PubMed ID: 428200
    [Abstract] [Full Text] [Related]

  • 20. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
    Pannuti F, Iafelice G, Martoni A, Fruet F, Angelelli B, Casadei M.
    Chemioterapia; 1984 Aug 15; 3(4):216-9. PubMed ID: 6398121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.